Editorial

Journal of Investigative Dermatology (1997) 109, 1–4; doi:10.1111/1523-1747.ep12276285

Lymphocyte Activation in the Pathogenesis of Psoriasis

David A Norris1, Jeffrey B Travers2 and Donald Y M Leung1,3

  1. 1Department of Dermatology, University of Colorado School of Medicine, Denver, Colorado, U.S.A
  2. 2Department of Dermatology, University Hospital, Indiana University, Indianapolis, Indiana, U.S.A
  3. 3Division of Pediatric Allergy-Immunology, National Jewish Center for Immunology and Respiratory Medicine, Denver, Colorado, U.S.A.
Top

References

  1. Baker, DS, Swain, AF, Fry, L., Valdimarsson, H.: Epidermal T lymphocytes and HLA-DR. expression in psoriasis. Br J Dermatol (1984) 110, 555–564,
  2. Baker, BS, Bokch, S., Powles, A., Garioch, JJ, Lewis, H., Valdimarsson, H., Fry, L.: Group A streptococcal antigen-specific T lymphocytes in guttate psoriatic lesions. Br J Dermatal (1993) 128, 493–499,
  3. Barker, JN, Karabin, GD, Stoof, TJ, Sarma, VJ, Dixit, VM, Nickoloff, BJ: Detection of interferon-gamma-mRNA in psoriatic epidermis by polymerase chain reaction. J Dermatol Sci (1991) 2, 106–111,  | Article | PubMed | ChemPort |
  4. Boehncke, WH, Dressel, D., Manfras, H, Zollner, TM, Wettstein, A., Bohm, BO, Sterry, W.: T-cell-receptor repertoire in chronic plaque-stage psoriasis is restricted and lacks enrichment of superantigen-associated Vbeta regions. J Invest Dermatol (1995) 104, 725–728,  | Article | PubMed | ISI | ChemPort |
  5. Boehnche, WH, Dressel, D., Zollner, TM, Kaufinann, R.: Pulling the trigger on psoriasis (letter). Nature (1996) 379, 777,
  6. Chang, JC, Smith, LR., Froning, KJ, Schwabe, BJ, Laxer, JA, Caralli, LL, Kurland, HH, Karasek, MA, Wilkinson, DI, Carlo, DJ: CD8+ T cells in psoriatic lesions preferentially use T-cell receptor Vbeta 3 and/or Vbeta 13.1 genes. Proc Natl Acad Sci (USA) 1994 91:9282–9286,
  7. Detmar, M., Brown, LF, Claffey, KP, Yeo, KT, Kocher, O., Jackman, RW, Berse, B., Dvorak, HF: Overexpression of vascular permeability factor/vascular endothelial growth factor and its receptors in psoriasis. J Exp Med (1994) 180, 1141–1146,  | Article | PubMed | ISI | ChemPort |
  8. Ezepechuk, YV, Leung, DYM, Middleton, MH, Bina, P., Reiser, R., Morris, DA: Staphylococcal toxins and protein A differentially induce cytotoxicity and release of minor necrosis factor-alpha from human keratinocytes. J Invest Dermatol (1996) 107, 603–609,
  9. Gottlieb, SL, Gilleaudeau, P., Johnson, R., Estes, L., Woodworth, TG, Gottlieb, AB, Krueger, JG: Response of psoriasis to a lymphocyte-selective toxin (DAB389IL-2) suggests a primary immune, but not a keratinocyte, pathogenesis. Nature Med (1995) 1, 442–447,  | Article |
  10. Gupta, AK, Ellis, CN, Nickoloff, BJ, Goldfarb, MT, Ho, VC, Rocher, LL, Griffiths, CE, Cooper, KD, Voorhees, JJ: Oral cyclosporine in the treatment of inflammatory and noninflammatory dermatoses. A clinical and immunopathologic analysis. Arch Dermatol (1990) 126, 339–350,
  11. Kalish, RS, Johnson, KL: Enrichment and function of uroshiol (poison-ivy)-specific T lymphocytes in lesions of allergic contact dermatitis to uroshiol. J Immunol (1990) 145, 3706–3713,  | PubMed | ISI | ChemPort |
  12. Kojima, T., Cromie, MA, Fisher, GJ, Voorhees, JJ, Elder, JT: GRO-beta mRNA is selectively overexpressed in psoriatic epidermis and is reduced by cyclosporin A in vivo, but not in cultured keratinocytes. J Invest Dermatol (1993) 101, 767–772,
  13. Leung, DY, Walsh, P., Giorno, R., Norris, DA: A potential role for superantigens in the pathogenesis of psoriasis. J Invest Dermatol (1993) 100, 225–228,  | Article | PubMed | ISI | ChemPort |
  14. Leung, DY, Gately, M., Trumble, A., Darnell, B., Schlievert, PM, Picker, LJ: Bacterial superantigens induce T-cell expression of the skin-selective homing receptor, the cutaneous lymphocyte-associated antigen, via stimulation of interleukin 12 production. J Exp Med (1995) 181, 747–753,  | Article | PubMed | ISI | ChemPort |
  15. Leung, DY, Travers, JB, Giorno, R., Norris, DA, Skinner, R., Aelion, J., Kazemi, LV, Kim, MH, Trumble, AE, Kotb, M.: Evidence for a streptococcal supcrantigen-driven process in acute guttate psoriasis. J Clin Invest (1995) 96, 2106–2112,  | PubMed | ISI | ChemPort |
  16. Lewis, HM, Baker, BS, Bokth, S., Powles, AV, Garioch, JJ, Valdimarsson, H., Fry, L.: Restricted T-cell receptor Vâ gene usage in the skin of patients with guttate and chronic plaque psoriasis. Br J Dermatol (1993) 129, 514–520,  | PubMed | ISI | ChemPort |
  17. McCluskey, RT, Benacerraf, B., McCluskey, JW: Studies on the specificity of the cellular infiltrate in delayed hypersensitivity reactions. J Exp. Med (1963) 90, 466–477,
  18. Menssen, A., Trommler, P., Vollmer, S., Schendel, D., Albert, E., Gurtler, L., Riethmuller, G., Prinz, JC: Evidence for an antigen-specific cellular immune response in skin lesions of patients with psoriasis vulgaris. J Immunol (1995) 155, 4078–4083,  | PubMed | ISI | ChemPort |
  19. Moss, P., Charmley, P., Mulbihill, E., Ziegler, S., Rangi, GJ, Kern, D., Piepkorn, M., Gelinas, R.: The repertoire of T cell antigen receptor beta-chain variable regions associated with psoriasis vulgaris. J Invest Dermatol (1997) 109, 14–19,  | Article | PubMed | ISI | ChemPort |
  20. Norris, DA, Leung, DYM: The role of superantigens in skin disease. In: Leung DYM, Huber BT, Schlievert PM, Eds. The Role of Superantigens in Inflammatory Skin Diseases. (1997) New York. Marcel Dekker, (in press)
  21. Parent, D., Bernard, BA, Desbas, C., Heenen, M., Darmon, MY: Spreading of psoriatic plaques: alteration of epidermal differentiation precedes capillary leakiness and anomalies in vascular morphology. J Invest Dermatol (1990) 95, 333–340,  | Article | PubMed | ISI | ChemPort |
  22. Schmitt-Egenolf, M., Boehncke, WH, Christophers, E., Stander, M., Sterry, W.: Type I and type II psoriasis show a similiar usage of T-cell receptor variable regions. J Invest Dermatol (1991) 97, 1053–1056,
  23. Schon, MP, Detmar, M., Parker, CM: Murine psoriasis-like disorder induced by naive CD4+ T cells. Nature Med (1997) 3, 183–188,  | Article |
  24. Strange, P., Cooper, KD, Hausen, ER, Fisher, G., Larsen, JK, Fox, D., Krag, C., Voorhees, JJ, Baadsgaard, O.: T-lymphocyte clones initiated from lesional psoriatic skin release groowth factors that induce keratinocyte proliferation. J Invest Dermatol (1993) 101, 695–700,  | Article | PubMed | ISI | ChemPort |
  25. Uyemura, K., Yamamamura, M., Fivenson, DF, Modlin, RL, Nickoloff, BJ: The cytokine network in lesional and lesion-tree psoriatic skin is characterized by a T-helper type 1 cell-mediated response. J Invest Dermatol (1993) 101, 701–705,  | Article | PubMed | ISI | ChemPort |
  26. Valdimarsson, H., Baker, BS, Jonsdottir, I., Powles, A., Fry, L.: Psoriasis: a T-cell-mediated autoimmune disease induced by streptococcal superantigens?. Immunol Today (1995) 16, 145–149,  | Article | PubMed | ISI | ChemPort |
  27. Vallat, VP, Gilleaudeau, P., Battat, L., Wolfe, J., Nabeya, R., Haytler, N., Hodak, E., Gottlieh, AB, Krueger, JG: PUVA bath therapy strongly suppresses immunological and epidermal activation in psoriasis: a possible cellular basis for remittive therapy. J Exp Med (1994) 180, 283–296,  | Article | PubMed | ISI | ChemPort |
  28. Vekony, MA, Holder, JE, Lee, AJ, Horrocks, C., Eperon, IC, Camp, RDR: Selective amplification of T-cell receptor variable region species is demonstrable but not essential in early lesions of psoriasis vulgaris: analysis by anchored polymerase chain reaction and hypervariable region size spectratyping. J Invest Dermatol (1997) 109, 5–13,  | Article | PubMed | ISI | ChemPort |
  29. Vollmer, S., Menssen, A., Trommler, P., Schendel, D., Prinz, JC: T lymphocytes derived from skin lesions of patients with psoriasis vulgaris express a novel cytokine pattern that is distinct from that of T helper type I and T helper type II cells. Eur J Immunol (1994) 24, 2377–2382,  | PubMed | ISI | ChemPort |
  30. Wrone-Smith, T., Nickoloff, BJ: Dermatol injection of immunocytes induces psoriasis. J Clin Invest (1996) 98, 1878–1887,  | PubMed | ChemPort |

Extra navigation

.
ADVERTISEMENT